1. Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA‐Matched Allogeneic Stem Cell Transplantation. Issue 8 (14th April 2015) Authors: Ritter, J.; Seitz, V.; Balzer, H.; Gary, R.; Lenze, D.; Moi, S.; Pasemann, S.; Seegebarth, A.; Wurdack, M.; Hennig, S.; Gerbitz, A.; Hummel, M. Journal: American journal of transplantation Issue: Volume 15:Issue 8(2015:Aug.) Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXCELLENT TRANSPLANT OUTCOMES WITH FLUDARABINE-TREOSULFAN (FT) REDUCED-TOXICITY CONDITIONING (RTC) IN COMBINATION WITH DUALT-CELL DEPLETION (TCD) IN MYELOABLATIVE CONDITIONING (MAC)-INELIGIBLE PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS). (May 2023) Authors: Pasic, I.; Remberger, M.; Chen, C.; Gerbitz, A.; Kim, D.; Kumar, R.; Lam, W.; Law, A.; Lipton, J.; Michelis, F.; Novitzky-Basso, I.; Viswabandya, A.; Mattsson, J. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT). (May 2023) Authors: Sayyed, A.; Altareb, M.; Chen, C.; Gerbitz, A.; Kim, D.; Lam, W.; Law, A.; Lipton, J.; Michelis, F.; Novitzky-Basso, I.; Viswabandya, A.; Kumar, R.; Mattsson, J.; Pasic, I. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗